Dr. Michael Sherling

Dr. Michael Sherling is the Chief Medical and Strategy Officer and co-founder of Modernizing Medicine.

Sherling is responsible for the strategy and medical innovation within Modernizing Medicine’s suite of products and services for dermatology, gastroenterology, ophthalmology, orthopedics, plastic surgery, otolaryngology and urology specialties. With Dan Cane, he has developed novel software solutions for EHR, MIPS and ICD-10 automation.

Under his leadership, Modernizing Medicine has established a user base of over 12,000 providers and raised over $332M in total investment.

Sherling is a dynamic speaker and has had the honor of speaking at the 2018 and 2017 Association of Dermatology Administrators & Managers (ADAM) Annual Meetings, the 2016 Dermatology Entrepreneurship Conference and 2015 Health 2.0 Conference’s “Tools to Fix the Clinical User Experience.”

Sherling has been a practicing dermatologist since 2006 and currently practices in a comprehensive skin care dermatology group in Palm Beach County, Florida. Sherling also serves on the Advisory Board for the Florida Atlantic University Charles E. Schmidt College of Medicine. Sherling is board certified by the American Board of Dermatology. Prior to relocating to Florida, he was the Associate Director of Laser Medicine and Skin Health at Brigham and Women’s Hospital in Boston and served as the Associate Residency Program Director for Harvard Medical School’s Department of Dermatology. He has several publications in peer-reviewed medical literature.

Sherling obtained his BS in Biology at Brown University with honors in 1996, his MD from Yale School of Medicine with honors in 2002 and his MBA from Yale School of Management in 2002. He received his clinical training at Harvard Medical School, where he served as chief resident in dermatology.